Received Jan 7, 2026
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| VARZOS | ZOSTER (SHINGRIX) | GLAXOSMITHKLINE BIOLOGICALS | UNK | — | — |
experienced an allergy; swollen arm/arm swelled up at injection site with pain; Painful arm/arm swelled up at injection site with pain; This non-serious case was reported by a consumer via call center representative and described the occurrence of injection site swelling in a 63-year-old female patient who received Herpes zoster (Shingrix) for prophylaxis. On 25-OCT-2019, the patient received Shingrix. On 25-OCT-2019, less than a day after receiving Shingrix, the patient experienced injection site swelling (Verbatim: swollen arm/arm swelled up at injection site with pain) and injection site pain (Verbatim: Painful arm/arm swelled up at injection site with pain). On an unknown date, the patient experienced allergy (Verbatim: experienced an allergy). On 30-OCT-2019, the outcome of the injection site swelling and injection site pain were resolved (duration 5 days). The outcome of the allergy was not reported. It was unknown if the reporter considered the injection site swelling, injection site pain and allergy to be related to Shingrix. It was unknown if the company considered the injection site swelling, injection site pain and allergy to be related to Shingrix. Additional Information: GSK Receipt Date: 05-JAN-2026 The patient self-reported this case for herself. Patient experienced an allergy after taking the Shingrix vaccine. Patient's arm swelled up at injection site with pain. Patient went to doctor about 5 days later; arm stayed swollen for about a week. The batch number was not provided and a request for this information has been made.